Skip NavigationSkip to Content

Whole-exome sequencing of nevoid basal cell carcinoma syndrome families and review of Human Gene Mutation Database PTCH1 mutation data

  1. Author:
    Gianferante, D Matthew [ORCID]
    Rotunno, Melissa
    Dean, Michael
    Zhou, Weiyin
    Hicks, Belynda
    Wyatt, Kathleen
    Jones, Kristine
    Wang, Mingyi
    Zhu, Bin
    Goldstein, Alisa M
    Mirabello, Lisa
  2. Author Address

    Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Division of Cancer Control and Population Science, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Cancer Genomics Research Laboratory, Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, Maryland.,
    1. Year: 2018
    2. Date: Nov
    3. Epub Date: 2018 11 08
  1. Journal: Molecular genetics & genomic medicine
    1. 6
    2. 6
    3. Pages: 1168-1180
  2. Type of Article: Article
  3. ISSN: 2324-9269
  1. Abstract:

    Nevoid basal cell carcinoma syndrome (NBCCS) is an autosomal dominant disorder with variable expression and nearly complete penetrance. PTCH1 is the major susceptibility locus and has no known hot spots or genotype-phenotype relationships. We evaluated 18 NBCCS National Cancer Institute (NCI) families plus PTCH1 data on 333 NBCCS disease-causing mutations (DM) reported in the Human Gene Mutation Database (HGMD). National Cancer Institute families underwent comprehensive genomic evaluation, and clinical data were extracted from NCI and HGMD cases. Genotype-phenotype relationships were analyzed using Fisher's exact tests focusing on mutation type and PTCH1 domains. PTCH1 pathogenic mutations were identified in 16 of 18 NCI families, including three previously mutation-negative families. PTCH1 mutations were spread across the gene with no hot spot. After adjustment for multiple tests, a statistically significant genotype-phenotype association was observed for developmental delay and gross deletion-insertions (p = 9.0 × 10-6 ), and suggestive associations between falx cerebri calcification and all transmembrane domains (p = 0.002) and severe outcomes and gross deletion-insertions (p = 4.0 × 10-4 ). Overall, 89% of our NCI families had a pathogenic PTCH1 mutation. The identification of PTCH1 mutations in previously mutation-negative families underscores the importance of repeated testing when new technologies become available. Additional clinical information linked to mutation databases would enhance follow-up and future studies of genotype-phenotype relationships. Published 2018. This article is a U.S. Government work and is in the public domain in the USA. Molecular Genetics & Genomic Medicine published by Wiley Periodicals, Inc.

    See More

External Sources

  1. DOI: 10.1002/mgg3.498
  2. PMID: 30411536
  3. WOS: 000454205500031

Library Notes

  1. Fiscal Year: FY2018-2019
NCI at FrederickClose Button

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel